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Repeated Topical Challenge with Chemical Antigen
Elicits Sustained Dermatitis in NC/Nga Mice in
Specific-Pathogen-Free Condition
Yoshiaki Tomimori, Yoshitaka Tanaka, Megumi Goto, and Yoshiaki Fukuda
Daiichi Suntory Biomedical Research Co. Ltd, Osaka, Japan
NC/Nga mice are known to develop skin lesions resembling to atopic dermatitis (AD) in conventional but not in
specific-pathogen-free (SPF) condition. An epicutaneous application of 2,4-dinitroﬂuorobenzene (DNFB) increased
skin thickness in C3H as well as NC/Nga mice in SPF environment, and the response was enlarged by repeating the
challenge at weekly intervals. Although the skin reaction in C3H mice was ameliorated when the challenge was
discontinued after the ﬁfth application, the reaction in NC/Nga mice was sustained at least for 3 wk. Analyses of
cytokine production by CD4þ cells from the draining lymph node proximal to the lesions revealed that, unlike C3H
mice, NC/Nga mice fail to induce T helper 2 (Th2) cytokine interleukin-4 (IL-4), whereas the level of Th1 cytokine
interferon-c in NC/Nga mice is equivalent to that of C3H mice. In addition, NC/Nga mice highly expressed IL-12, a
cytokine-preventing formation of Th2 response, whereas C3H mice did not. Administration of anti-IL-12 antibody
reduced duration of dermatitis in DNFB-treated NC/Nga mice. Taken together, our data suggest that IL-12 plays a
role in the persistent skin reaction in NC/Nga mice. The action of IL-12 might be mediated by the decrease in IL-4
production.
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Atopic dermatitis (AD) is a chronic eczematous skin disorder
with dry and itchy skin. Patients with AD often have a family
history of other allergic diseases including asthma and hay
fever. In acute lesions of AD, there is a significant increase in
the number of cells expressing T helper 2 (Th2) cytokines
such as interleukin-4 (IL-4) and IL-5 (Yamada et al, 1995).
However, delayed-type allergic reaction and Th1 immune
response are also likely involved in pathogenesis in AD. For
example, the skin lesions of AD are histologically indistin-
guishable from those of allergic contact dermatitis (Akdis
et al, 2000). In addition, expression of the Th1 cytokine in-
terferon-g (IFN-g) predominates in chronic skin lesions of
some patients with AD (Grewe et al, 1995; Werfel et al, 1996)
and correlates to the severity of the disease (Grewe et al,
1994).
An epicutaneous application with chemical antigens
such as 2,4-dinitrofluorobenzene (DNFB) evokes contact
hypersensitivity reaction in mice that had previously been
sensitized with the same agents. Interestingly, repetition of
the topical application with such agents induces not only a
shift in kinetics of the skin reaction from delayed-type to
immediate-type response (Kitagaki et al, 1995; Nagai et al,
1997), but also change the cytokine milieu from Th1 to Th2
profile (Kitagaki et al, 1997; Nagai et al, 1997). This exper-
imental system is therefore useful for studying role of Th1
and Th2 in skin inflammation.
NC/Nga mice were established as an inbred strain from
Japanese fancy mice in 1957, and have recently been shown
to spontaneously develop AD-like dermatitis with immuno-
globulin (Ig)E hyperproduction in air-uncontrolled, conven-
tional circumstance (Matsuda et al, 1997; Watanabe et al,
2002). NC/Nga mice, however, show no skin lesion when
raised in specific-pathogen-free (SPF) condition. The other
strains such as BALB/c mice never develop dermatitis even if
they are housed with NC/Nga mice, suggesting an involve-
ment of inheritable factor in the pathogenesis of the mice.
In this study, the effect of topical challenge with chemical
antigen on skin reaction was investigated using NC/Nga
mice in order to elucidate the role of Th1 and Th2 responses
in AD. The results showed that repeated painting with DNFB
elicits skin lesion in NC/Nga mice under SPF condition, like
in other stains, and that the skin inflammation in NC/Nga
mice exclusively prolongs even after the challenge was
discontinued. Our data also suggested that IL-12-mediated
deficiency in IL-4 expression might be associated with
the prolongation of the dermatitis in DNFB-treated NC/Nga
mice.
Results
Change in ear thickness of NC/Nga and C3H mice fol-
lowing DNFB treatment An epicutaneous application of
DNFB to ear elicits a transient skin reaction in C3H mice
Abbreviations: AD, atopic dermatitis; anti-TCR, anti-T-cell receptor;
DNFB, 2,4-dinitrofluorobenzene; IFN, interferon; Ig, immunoglob-
ulin; IL, interleukin; SPF, specific-pathogen free; Th2, T helper 2
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(Tomimori et al, 2002). Repeating the challenge with DNFB
weekly five times not only enhanced the transient response
to DNFB, but also increased baseline of skin thickness in
C3H as well as NC/Nga mice (Fig 1A). After the application
was discontinued following the fifth challenge, the skin re-
sponse was ameliorated gradually in C3H mice and disap-
peared completely by 3 wk after the last challenge. In
contrast, the skin thickness of NC/Nga mice remained close
to that at 6 wk at least for 3 wk. The prolonged skin reaction
induced in NC/Nga mice appears to be specific for DNFB,
since 12-O-tetradecanoylphorbol 13-acetate (TPA) painting
induced a transient skin reaction in C3H and NC/Nga mice,
which was improved similarly in the two strains of mice even
after the fifth challenge (Fig 1B).
Change in serum IgE Level of NC/Nga and C3H mice
following DNFB treatment As shown in Fig 2, serum IgE
concentration in C3H mice started to increase after the
fourth application of DNFB and reached to the maximal
level at 7 wk of the experiment. The IgE level was subse-
quently declined and returned to the basal level by 9 wk.
The serum IgE in DNFB-treated NC/Nga mice showed sim-
ilar kinetics for 6 wk, whereas the level was higher than that
in C3H mice at all the time points over the period. The IgE
level in the NC/Nga mice, however, did not decrease even
after the challenge was discontinued (Fig 2).
Histological analysis of DNFB-treated ears in NC/Nga
and C3H mice Figure 3 shows the representative results of
histological analyses in the skin lesions of DNFB-treated
mice. In the skin lesion at 6 wk, hyperplasia and thickening
of epidermis were evident and cell infiltration was marked in
NC/Nga (Fig 3B) and C3H mice (Fig 3E ) compared with the
unaffected control mice (Fig 3A,D). At 9 wk, however, such
changes were progressively reduced in C3H mice (Fig 3F ).
In contrast, the epidermis still remained thick and cell ac-
cumulation was observed in the skin lesions of NC/Nga
mice even at 9 wk (Fig 3C).
Synthesis of IL-4 and IFN-c by CD4þ lymph node cells
from NC/Nga and C3H mice Next, production of Th1 and
Th2 cytokines was compared between the two strains of
mice. CD4þ Tcells were prepared from cervical lymph nodes
and stimulated with anti-T-cell receptor (anti-TCR) plus anti-
CD28 antibodies, and their ability to synthesize IL-4 and IFN-
g was assessed by ELISA. As shown in Fig 4A,B, the levels of
IL-4 and IFN-g produced by CD4þ cells from C3H mice
treated with DNFB five times were significantly higher than
those of the unaffected control mice. Similar results were
obtained in C3H mice at 9 wk of the experiment (Fig 4C,D). In
NC/Nga mice, however, IL-4 production by CD4þ cells was
not significant at 6 and 9 wk (Fig 4A,C), whereas IFN-g pro-
duction was almost similar to that in C3H (Fig 4B,D).
Content of IL-18 and IL-12 in the skin lesions of NC/Nga
and C3H mice The IL-18 content in the lesions was sig-
nificantly higher in DNFB-treated NC/Nga and C3H mice
compared with their control mice at 6 wk (Fig 5A), whereas
that in C3H decreased thereafter (Fig 5C). The content of IL-
12 was much higher in NC/Nga mice at 6 and 9 wk (Fig
5B,D), whereas the IL-12 level was little at 3 wk (data
not shown). In contrast to NC/Nga mice, the level of IL-12
in the lesions of C3H was little, if any, even at 6 and 9 wk
(Fig 5B,D).
Figure 1
Change in ear thickness by repeated challenge with 2,4-dinitro-
fluorobenzene (DNFB) or 12-O-tetradecanoylphorbol 13-acetate
(TPA) in NC/Nga and C3H mice. Skin inflammation was induced by
topical application of DNFB (A) or TPA (B) to ears five times at 7 d
intervals and ear thickness was determined as described in Materials
and Methods. Data are mean  SEM (n¼ 5–7). po0.05, po0.01
compared with C3H mice (Student’s t test).
Figure2
Change in serum immunoglobulin (Ig)E level by repeated challenge
with 2,4-dinitrofluorobenzene (DNFB) in NC/Nga and C3H mice.
Skin inflammation was induced by topical application of DNFB to ears
five times at 7 d intervals and serum IgE concentration was measured
as described in Materials and Methods. Data are mean  SEM (n¼ 3).
po0.05 compared with C3H mice (Student’s t test).
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Effect of anti-IL-12 antibody on prolongation of derma-
titis in NC/Nga mice When anti-IL-12 antibody was ad-
ministered to the DNFB-treated NC/Nga mice intravenously
twice a week starting at 6 wk of the experiment, the estab-
lished ear edema was dramatically ameliorated (Fig 6). In
contrast, the isotype-matched normal IgG showed little ef-
fect. These results suggest that IL-12 might participate in
the prolongation of skin reaction in NC/Nga mice.
Figure 3
Histological analyses of skin lesions in
2,4-dinitrofluorobenzene (DNFB)-treat-
ed NC/Nga and C3H/HeN mice. Skin
inflammation was induced by topical ap-
plication of DNFB to ears five times at 7 d
intervals as described in Materials and
Methods. Ears were excised at 6 (A, B, D,
and E) and 9 (C, F) wk, and the ear sec-
tions were stained with hematoxylin and
eosin. (A, D) Unaffected control; (A–C)
NC/Nga mice; (D–F) C3H mice. Original
magnification  100, Scale bar¼50 mm
for all pictures.
Figure 4
Production of interleukin (IL)-4 and
interferon (IFN)-c by CD4þ cervical
lymph node cells from 2,4-dinitroflu-
orobenzene (DNFB)-treated NC/Nga
and C3H mice. Skin inflammation was
induced by topical application of DNFB
to ears as described in Materials and
Methods. CD4þ cells were prepared
from cervical lymph node of the mice at
6 (A, B) and 9 (C, D) wk and stimulated
with TCR and CD28 for 48 h. IL-4 and
IFN-g concentrations in the culture
medium were measured by ELISA.
(A, C) IL-4; (B, D) IFN-g. Data are
mean  SEM (n¼ 4). po0.01 com-
pared with unaffected control group,
##po0.01 compared with DNFB-treat-
ed C3H mice (Student’s t test).
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Discussion
NC/Nga mice spontaneously develop eczematous skin
lesions when maintained in conventional but not in SPF
condition, indicating that the conventional NC/Nga mice are
a useful animal model for AD. Under conventional environ-
ment, however, microbial and pathogen statuses vary be-
tween animal facilities, which could affect the incidence and
severity of the disease of the mice. The data in this study
showed that NC/Nga mice in SPF condition develop der-
matitis with IgE hyperproduction following repeated painting
with DNFB, and that the reaction in NC/Nga but not in C3H
mice continues even after the painting is stopped. The
mouse model presented in this study is valuable for stud-
ying pathogenesis of AD under SPF condition.
Repeated painting with DNFB increased expression of
IFN-g and IL-4 by CD4þ T cells from cervical lymph node in
C3H mice (Fig 4). In contrast, the level of IFN-g produced by
CD4þ cells from NC/Nga was higher than that from the
control mice, but that of IL-4 was not. IFN-g is known to be
associated with chronicity of AD lesions (Grewe et al, 1994),
and IL-4 antagonizes the function of IFN-g (Paludan, 1998).
It is therefore possible that the deficiency in IL-4 expression
may be involved in the sustained skin reaction in DNFB-
treated NC/Nga mice.
The failure of NC/Nga mice to express IL-4 after repeated
DNFB challenge raises the idea that the mechanism under-
lying the hyperproduction of IgE and its continuation in the
mice is not necessarily dependent on the level of IL-4, which
is the major cytokine for IgE synthesis (Kuhn et al, 1991).
Recently, Matsumoto et al (1999) have shown that hyper-
production of IgE by conventional NC/Nga mice is attrib-
uted to constitutive phosphorylation of Janus kinase 3
(JAK3), a non-receptor protein tyrosine kinase involved in
IL-4 signaling (Witthuhn et al, 1994). Thus it is also possible
that repeated painting with DNFB in SPF condition induces
Figure5
Expression of interleukin (IL)-18 and IL-
12 in the skin lesions of 2,4-dinitroflu-
orobenzene (DNFB)-treated NC/Nga
and C3H mice. Skin inflammation was
induced by topical application of DNFB to
ears as described in Materials and meth-
ods. IL-18 and IL-12 content in the skin
lesions was determined at 6 (A, B) and 9
(C, D) wk by measuring their concentra-
tion in the supernatant of homogenate
in the lesions by ELISA. (A, C) IL-18;
(B, D) IL-12. Data are mean  SEM
(n¼ 5). po0.01 compared with unaf-
fected control group, ##po0.01 compared
with DNFB-treated C3H mice (Student’s
t test).
Figure 6
Effect of anti-interleukin (IL)-12 antibody on the prolongation of the
dermatitis. Skin inflammation was induced by topical application of
2,4-dinitrofluorobenzene (DNFB) to ears as described in Materials and
Methods. Rat anti-mouse IL-12 (open square), rat immunoglobulin
(Ig)G1 (closed square), and saline (open circle) were administered in-
travenously twice a week, starting at 6 wk of the experiment. Open
triangle, unaffected control group. Data are mean  SEM (n¼ 3).
po0.01 compared with rat IgG-treated group (Dunnett’s t test).
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continuous JAK3 phosphorylation exclusively in NC/Nga
mice. If so, SPF NC/Nga mice could produce excessive IgE
either in response to the marginal level of or without IL-4. An
alternative explanation for IgE hyperproduction in DNFB-
treated NC/Nga mice would be a participation of IL-13,
which induces IL-4-independent IgE synthesis (Punnonen
et al, 1993).
The expression of IL-18 and IL-12 increased in the skin
lesions of DNFB-treated NC/Nga, whereas C3H mice ex-
pressed high level of IL-18 but not IL-12 (Fig 5), suggesting
that the IL-12 is also involved in the difference in kinetics of
DNFB-induced dermatitis between NC/Nga and C3H mice.
In fact, administration of anti-IL-12 antibody ameliorated the
established dermatitis in NC/Nga mice (Fig 6). Thus, these
findings suggest that IL-12 may participate in the chronicity
of skin inflammation, in agreement with the finding that the
IL-12-positive cells increase in chronic skin lesions com-
pared with acute lesions and uninvolved skin from AD pa-
tients (Hamid et al, 1996). Since it is known that IL-12 favors
Th1 differentiation (Trinchieri, 2003), the ability of IL-12 to
prolong skin reaction could be mediated by IL-4 deficiency.
The role of IL-18 in pathogenesis of AD patients and NC/
Nga mice has been controversial. It has been shown that IL-
18 is elevated in the sera from patients with AD and from
NC/Nga mice (Tanaka et al, 2001), and that KIL-18Tg, the
transgenic mice that overexpress IL-18 in their keratin-
ocytes, spontaneously develop AD-like skin disease (Ko-
nishi et al, 2002). On the contrary, Habu et al (2001) have
reported the data conflicting with this idea, i.e., treatment of
NC/Nga mice with IL-18 substantially inhibited elevation of
the serum IgE levels, serum IL-4 levels and dermatitis under
conventional condition. More recently, in addition, it has
been reported that continuous injections of anti-IL-18 an-
tibody do not inhibit the onset and development of derma-
titis and IgE elevation in conventional NC/Nga mice, and
that the treatment rather leads to an exacerbation of der-
matitis and scratching behavior of the mice (Higa et al,
2003). The mechanism for the induction of dermatitis might
differ between conventional and SPF conditions.
Materials and Methods
Mice SPF NC/Nga and C3H/HeN (C3H) mice were purchased
from Charles River Japan (Kanagawa, Japan) and CLEA Japan
(Tokyo, Japan), respectively, and maintained in SPF condition. All
animal experiments were approved by Institutional Review Board
for animal studies of Daiichi Suntory Biomedical Research Co. Ltd.
DNFB-induced dermatitis Allergic dermatitis was induced by re-
peated topical application with DNFB as described (Tomimori et al,
2002). Briefly, 25 mL of 0.15% DNFB in acetone/olive oil (3:1) was
applied to each side of right ears of mice five times at 7 d intervals.
Ear thickness was measured 0, 24, 48, and 72 h after each painting
using a thickness gauge (Digimatic Indicator, Mitsutoyo, Tokyo,
Japan), and increase in ear thickness was determined by sub-
tracting ear thickness before the first painting from that of each
time point. To examine continuation of the skin inflammation,
measurement of ear thickness was similarly performed for addi-
tional 3 wk after the challenge was stopped. To examine the effect
of anti-IL-12 antibody, in addition, either 150 mg of rat anti-mouse
IL-12 (C15.6, Biosource, Camarillo, California), the same amount of
rat IgG1 (BD Pharmingen, San Diego, California) or saline was
administered intravenously twice a week starting at 6 wk of the
experiment, and ear thickness was measured at 6 and 8 wk. In
some experiments, the same volume of solvent for DNFB was
painted instead of DNFB solution as unaffected control. Further-
more, 20 mL of 0.005% TPA in acetone was applied instead of
DNFB so as to examine the specificity of the effect of DNFB.
Serum IgE measurement Blood samples were collected once
a week and IgE concentration in the serum was quantified using
mouse IgE EIA kit (Yamasa Corp., Tokyo, Japan).
Histological analysis Ear samples were fixed in 10% (v/v) buff-
ered formalin, embedded in paraffin, sectioned at 4 mm, and then
stained with hematoxylin and eosin.
Measurement of cytokine production in vitro Measurement of
cytokine production was carried out as described (Nakanishi et al,
2001) with a slight modification. Briefly, the cervical lymph node
was excised from mice and CD4þ cells were purified using MACS
separation column (Daiichi Pure Chemicals, Tokyo, Japan) accord-
ing to the manufacturer’s procedure. The purified CD4þ cells
(5  105 cells per mL) were stimulated with plate-bound hamster
anti-mouse TCR (H57-597, Beckman Coulter K.K., Tokyo, Japan)
plus soluble form of hamster anti-mouse CD28 (PV-1, Southern
Biotech, Birmingham, Alabama) for 48 h in RPMI-1640 supple-
mented with 10% fetal bovine serum, 50 mM of b-mercaptoethanol
(Wako Pure Chemical, Osaka, Japan), and 2 mM glutamine (2 mM,
GIBCO, Invitrogen Corp., Carlsbad, California). Then IL-4 and IFN-
g in the supernatant were quantified by ELISA kit (Biosource).
Measurement of cytokine contents in the skin lesions Ear
samples were excised from mice and homogenized in 20 mM Tris-
HCL buffer, pH7.5 (10 times volume of the tissue weight), and their
homogenate was centrifuged at 10,000  g for 10 min. IL-12 and
IL-18 concentration in the supernatant of the homogenate was
quantified by ELISA kit for IL-12 (Biosource) and IL-18 (MBL,
Nagoya, Japan), respectively.
Statistical analysis The statistical analysis was performed with
Dunnett’s multiple comparison test or Student’s t test using Super
ANOVA (Abacus Concepts, Berkeley, California) or Statview (SAS
Institute Inc., Cary, North Carolina), respectively. A p-value less
than 0.05 was considered significant.
DOI: 10.1111/j.0022-202X.2004.23516.x
Manuscript received February 17, 2004; revised July 28, 2004; ac-
cepted for publication August 16, 2004
Address correspondence to: Yoshiaki Fukuda, PhD, Daiichi Suntory
Biomedical Research Co. Ltd, 1-1-1 Wakayamadai, Shimamoto-cho,
Mishima-gun, Osaka 618-8513, Japan. Email: Yoshiaki_Fukuda@dsup.
co.jp
References
Akdis CA, Akdis M, Trautmann A, Blaser K: Immune regulation in atopic derma-
titis. Curr Opin Immunol 12:641–646, 2000
Grewe M, Gyufko K, Schopf E, Krutmann J: Lesional expression of interferon-
gamma in atopic eczema. Lancet 343:25–26, 1994
Grewe M, Walther S, Gyufko K, Czech W, Schopf E, Krutmann J: Analysis of the
cytokine pattern expressed in situ in inhalant allergen patch test reactions
of atopic dermatitis patients. J Invest Dermatol 105:407–410, 1995
Habu Y, Seki S, Takayama E, et al: The mechanism of a defective IFN-gamma
response to bacterial toxins in an atopic dermatitis model, NC/Nga mice,
and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis.
J Immunol 166:5439–5447, 2001
Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY: In vivo
expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol
98:225–231, 1996
CHEMICAL ANTIGEN-INDUCED SUSTAINED DERMATITIS 123124 : 1 JANUARY 2005
Higa S, Kotani M, Matsumoto M, et al: Administration of anti-interleukin 18 an-
tibody fails to inhibit development of dermatitis in atopic dermatitis-model
mice NC/Nga. Br J Dermatol 149:39–45, 2003
Kitagaki H, Fujisawa S, Watanabe K, Hayakawa K, Shiohara T: Immediate-type
hypersensitivity response followed by a late reaction is induced by
repeated epicutaneous application of contact sensitizing agents in mice.
J Invest Dermatol 105:749–755, 1995
Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, Shiohara T: Repeated
elicitation of contact hypersensitivity induces a shift in cutaneous cyto-
kine milieu from a T helper cell type 1 to a T helper cell type 2 profile.
J Immunol 159:2484–2491, 1997
Konishi H, Tsutsui H, Murakami T, et al: IL-18 contributes to the spontaneous
development of atopic dermatitis-like inflammatory skin lesion independ-
ently of IgE/stat6 under specific pathogen-free conditions. Proc Natl
Acad Sci USA 99:11340–11345, 2002
Kuhn R, Rajewsky K, Muller W: Generation and analysis of interleukin-4 deficient
mice. Science 254:707–710, 1991
Matsuda H, Watanabe N, Geba GP, et al: Development of atopic dermatitis-like
skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9:
461–466, 1997
Matsumoto M, Ra C, Kawamoto K, et al: IgE hyperproduction through
enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga
mice, a model for human atopic dermatitis. J Immunol 162:1056–1063,
1999
Nagai H, Matsuo A, Hiyama H, Inagaki N, Kawada K: Immunoglobulin E pro-
duction in mice by means of contact sensitization with a simple chemical,
hapten. J Allergy Clin Immunol 100:S39–S44, 1997
Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 regulates both
Th1 and Th2 responses. Annu Rev Immunol 19:423–474, 2001
Paludan SR: Interleukin-4 and interferon-gamma: The quintessence of a mutual
antagonistic relationship. Scand J Immunol 48:459–468, 1998
Punnonen J, Aversa G, Cocks BG, et al: Interleukin 13 induces interleukin 4-
independent IgG4 and IgE synthesis and CD23 expression by human B
cells. Proc Natl Acad Sci USA 90:3730–3734, 1993
Tanaka T, Tsutsui H, Yoshimoto T, et al: Interleukin-18 is elevated in the sera from
patients with atopic dermatitis and from atopic dermatitis model mice,
NC/Nga. Int Arch Allergy Immunol 125:236–240, 2001
Tomimori Y, Muto T, Fukami H, et al: Chymase participates in chronic dermatitis
by inducing eosinophil infiltration. Lab Invest 82:789–794, 2002
Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive
immunity. Nat Rev Immunol 3:133–146, 2003
Watanabe N, Tomimori Y, Saito K, Miura K, Wada A, Tsudzuki M, Fukuda Y:
Chymase inhibitor improves dermatitis in NC/Nga mice. Int Arch Allergy
Immunol 128:229–234, 2002
Werfel T, Morita A, Grewe M, Renz H, Wahn U, Krutmann J, Kapp A: Allergen
specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine
pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 107:
871–876, 1996
Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN: Involve-
ment of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in
lymphoid and myeloid cells. Nature 370:153–157, 1994
Yamada N, Wakugawa M, Kuwata S, Yoshida T, Nakagawa H: Chronologic anal-
ysis of in situ cytokine expression in mite allergen-induced dermatitis in
atopic subjects. J Allergy Clin Immunol 96:1069–1075, 1995
124 TOMIMORI ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
